Quarterly report pursuant to Section 13 or 15(d)

Fair Value of Financial Instruments - Impairment of Equity Method Investments and Long-Lived Assets (Details)

v3.23.4
Fair Value of Financial Instruments - Impairment of Equity Method Investments and Long-Lived Assets (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Nov. 30, 2023
Nov. 30, 2022
Nov. 30, 2023
Nov. 30, 2022
Aug. 31, 2023
May 31, 2023
Aug. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]              
Equity method investments, total losses $ 0.3 $ 0.0 $ 136.1 $ 1,060.3      
Corporate Venture Capital, Equity Method Investments, 8/23 Impairment              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]              
Equity method investments, carrying value         $ 14.9    
Equity method investments         $ 2.6    
Equity method investments, total losses     12.3        
Canopy Equity Method Investment              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]              
Equity method investments, carrying value           $ 266.2 $ 1,695.1
Equity method investments           $ 142.7 $ 634.8
Equity method investments, total losses   $ 1,060.3 $ 123.5 $ 1,060.3